Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

被引：0
作者：
Stefan, Norbert [1 ,2 ,3 ,6 ]
Roden, Michael [1 ,4 ,5 ]
机构：
[1] Deutsch Zentrum Diabetesforsch DZD, Neuherberg, Germany
[2] Univ Klinikum Tubingen, Lehrstuhl Klin Experimentelle Diabetol, Abt Innere Med 4, Bere Endokrinol Diabetol & Nephrol, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Helmholtz Zentrums Munchen, Inst Diabetesforschung & Metab Erkrankungen IDM, Abt Pathophysiol Pradiabetes, Tubingen, Germany
[4] Heinrich Heine Univ Dusseldorf, Deutsch Diabet Zentrum DDZ, Leibniz Zentrum Diabet Forsch, Dusseldorf, Germany
[5] Heinrich Heine Univ, Med Fak, Klin Endokrinol & Diabetol, Dusseldorf, Germany
[6] Univ Klinikum Tubingen, Otfried Muller Str 10, D-72076 Tubingen, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2024年 / 19卷
关键词：
NONALCOHOLIC FATTY LIVER; CONTROLLED-TRIAL;
D O I：
10.1055/a-2312-0452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S290 / S296
页数：7
相关论文
共 50 条
  • [1] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [2] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [3] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [4] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [5] Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Nendouvhada, Livhuwani P.
    Sibuyi, Nicole R. S.
    Fadaka, Adewale O.
    Meyer, Samantha
    Madiehe, Abram M.
    Meyer, Mervin
    Gabuza, Kwazikwakhe B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [6] Natural history of metabolic dysfunction-associated steatotic liver disease
    Lekakis, Vasileios
    Papatheodoridis, George, V
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 3 - 10
  • [7] Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
    Ni, Keying
    Meng, Lina
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
  • [8] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [9] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [10] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
    Sawada, Keisuke
    Chung, Hak
    Softic, Samir
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    CELL METABOLISM, 2023, 35 (11) : 1852 - 1871
12345